Literature DB >> 18922769

Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits.

Romain H Fontaine1, Paul Olivier, Véronique Massonneau, Philippe Leroux, Vincent Degos, Sophie Lebon, Vincent El Ghouzzi, Vincent Lelièvre, Pierre Gressens, Olivier Baud.   

Abstract

White-matter damage is a leading cause of neurological handicap. Although hypoxia-ischemia and excitotoxicity are major pathogenic factors, a role for genetic influences was suggested recently. Thus, protracted gestational hypoxia was associated with white-matter damage (WMD) in rat pups but not in mouse pups. Indeed, microglial activation and vessel-wall density on postnatal days (P)1 and P10 were found increased in both mouse and rat pups, but cell death, astrogliosis, and myelination were only significantly altered in hypoxic rat pups. We investigated whether this species-related difference was ascribable to effects of antenatal hypoxia on the expression of glutamate receptor subunits by using immunocytochemistry, PCR, and excitotoxic double hit insult. Quantitative PCR in hypoxic mouse pups on P1 showed 2- to 4-fold down-regulation of the AMPA-receptor subunits -1, 2, and -4; of the kainate-receptor subunit GluR7; and of the metabotropic receptor subunits mGluR1, -2, -3, -5, and -7. None of the glutamate-receptor subunits was down-regulated in the hypoxic rat pups. NR2B was the only NMDA-receptor subunit that was down-regulated in hypoxic mice but not in hypoxic rat on P1. Ifenprodil administration to induce functional inhibition of NMDA containing NR2B-subunit receptors prevented hypoxia-induced myelination delay in rat pups. Intracerebral injection of a glutamate agonist produced a larger decrease in ibotenate-induced excitotoxic lesions in hypoxic mouse pups than in normoxic mouse pups. Gestational hypoxia may regulate the expression of specific glutamate-receptor subunits in fetal mice but not in fetal rats. Therefore, genetic factors may influence the susceptibility of rodents to WMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922769      PMCID: PMC2575496          DOI: 10.1073/pnas.0803004105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  A radiation hybrid map of the rat genome containing 5,255 markers.

Authors:  T K Watanabe; M T Bihoreau; L C McCarthy; S L Kiguwa; H Hishigaki; A Tsuji; J Browne; Y Yamasaki; A Mizoguchi-Miyakita; K Oga; T Ono; S Okuno; N Kanemoto; E Takahashi; K Tomita; H Hayashi; M Adachi; C Webber; M Davis; S Kiel; C Knights; A Smith; R Critcher; J Miller; T Thangarajah; P J Day; J R Hudson; Y Irie; T Takagi; Y Nakamura; P N Goodfellow; G M Lathrop; A Tanigami; M R James
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 2.  Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.

Authors:  J W McDonald; M V Johnston
Journal:  Brain Res Brain Res Rev       Date:  1990 Jan-Apr

3.  Cloning and characterization of promoter and 5'-UTR of the NMDA receptor subunit epsilon 2: evidence for alternative splicing of 5'-non-coding exon.

Authors:  M Klein; I Pieri; F Uhlmann; K Pfizenmaier; U Eisel
Journal:  Gene       Date:  1998-02-27       Impact factor: 3.688

4.  Comparative genome mapping: mouse and rat homologies revealed by fluorescence in situ hybridization.

Authors:  J M Scalzi; J C Hozier
Journal:  Genomics       Date:  1998-01-01       Impact factor: 5.736

5.  Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.

Authors:  P Gressens; S Marret; J M Hill; D E Brenneman; I Gozes; M Fridkin; P Evrard
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Distinct N-methyl-D-aspartate receptor 2B subunit gene sequences confer neural and developmental specific expression.

Authors:  M Sasner; A Buonanno
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

7.  Comparative mapping of mouse and rat chromosomes by fluorescence in situ hybridization.

Authors:  F Grützner; H Himmelbauer; M Paulsen; H H Ropers; T Haaf
Journal:  Genomics       Date:  1999-02-01       Impact factor: 5.736

8.  Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain.

Authors:  J Zhong; D P Carrozza; K Williams; D B Pritchett; P B Molinoff
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

9.  Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain.

Authors:  R Ann Sheldon; Alexandra Aminoff; Christina L Lee; Stephan Christen; Donna M Ferriero
Journal:  Pediatr Res       Date:  2007-06       Impact factor: 3.756

10.  Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions.

Authors:  S Marret; R Mukendi; J F Gadisseux; P Gressens; P Evrard
Journal:  J Neuropathol Exp Neurol       Date:  1995-05       Impact factor: 3.685

View more
  10 in total

1.  Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.

Authors:  Rujin Tian; Xiaoping Wu; Tracy L Hagemann; Alexandre A Sosunov; Albee Messing; Guy M McKhann; James E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

Review 2.  A Critical Evaluation of Current Concepts in Cerebral Palsy.

Authors:  Joline E Brandenburg; Matthew J Fogarty; Gary C Sieck
Journal:  Physiology (Bethesda)       Date:  2019-05-01

Review 3.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

4.  Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.

Authors:  Justin M Dean; Matthew D Moravec; Marjorie Grafe; Nicholas Abend; Jennifer Ren; Xi Gong; Joseph J Volpe; Frances E Jensen; A Roger Hohimer; Stephen A Back
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

5.  Transcriptomes Suggest That Pinniped and Cetacean Brains Have a High Capacity for Aerobic Metabolism While Reducing Energy-Intensive Processes Such as Synaptic Transmission.

Authors:  Cornelia Geßner; Alena Krüger; Lars P Folkow; Wilfrid Fehrle; Bjarni Mikkelsen; Thorsten Burmester
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

6.  Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat.

Authors:  Julien Pansiot; Gauthier Loron; Paul Olivier; Romain Fontaine; Christiane Charriaut-Marlangue; Jean-Christophe Mercier; Pierre Gressens; Olivier Baud
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

7.  Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?

Authors:  Xavier Durrmeyer; Shushanik Hovhannisyan; Yves Médard; Evelyne Jacqz-Aigrain; Fabrice Decobert; Jérome Barre; Corinne Alberti; Yannick Aujard; Claude Danan; Olivier Baud
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

Review 8.  Focal necrosis and disturbed myelination in the white matter of newborn infants: a tale of too much or too little oxygen.

Authors:  Sven Wellmann; Christoph Bührer; Thomas Schmitz
Journal:  Front Pediatr       Date:  2015-01-12       Impact factor: 3.418

9.  Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia.

Authors:  Dimitri Hefter; Hugo H Marti; Peter Gass; Dragos Inta
Journal:  Front Psychiatry       Date:  2018-03-29       Impact factor: 4.157

10.  Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats.

Authors:  Paul Olivier; Romain H Fontaine; Gauthier Loron; Juliette Van Steenwinckel; Valérie Biran; Véronique Massonneau; Angela Kaindl; Jeremie Dalous; Christiane Charriaut-Marlangue; Marie-Stéphane Aigrot; Julien Pansiot; Catherine Verney; Pierre Gressens; Olivier Baud
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.